

Analysts raised targets for Microsoft, VF, Glaukos, Hilton, AxoGen and Brinker; Renasant’s target was cut and its rating downgraded.
You can purchase shares of Axogen (NASDAQ:AXGN) through any online brokerage.
Other companies in Axogen’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Axogen has a consensus price target of $45.29.
The stock price for Axogen (NASDAQ: AXGN) is $49 last updated October 29, 2026 at 5:14 PM EDT.
There are no upcoming dividends for Axogen.
Axogen does not have any upcoming earnings scheduled.
There is no upcoming split for Axogen.
Axogen is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers....